{
  "legislationId": "119_HR_7867",
  "lastUpdate": "2026-03-27T12:23:54.655Z",
  "history": [
    {
      "timestamp": "2026-03-27T12:23:54.655Z",
      "source_url": "https://www.congress.gov/119/bills/hr7867/BILLS-119hr7867ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7867 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7867 To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 9, 2026 Ms. DeLauro (for herself, Mrs. Grijalva, Mr. Panetta, Ms. Jacobs, Ms. Norton, Ms. Wilson of Florida, Mr. Bishop, Ms. Williams of Georgia, Mr. Pappas, Mr. Quigley, Mr. Krishnamoorthi, Ms. Schakowsky, Ms. Tlaib, Mr. Thanedar, Ms. Ross, Mr. Van Drew, Ms. Dean of Pennsylvania, and Mr. Cohen) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Infant Formula Safety Modernization Act of 2026''. SEC. 2. MEASURES TO ENHANCE THE SAFETY OF INFANT FORMULA. (a) Good Manufacturing Practices.-- (1) In general.--Section 412(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b)) is amended by adding at the end the following: ``(5)(A) The Secretary shall by regulation update the good manufacturing practices for infant formulas established under this subsection to require the manufacturer of an infant formula to conduct pathogen and microorganism testing of-- ``(i) the infant formula manufacturing facilities of the manufacturer; and ``(ii) in addition to other applicable testing requirements under this Act, the finished infant formula product of the manufacturer. ``(B) The regulations issued under subparagraph (A) shall-- ``(i) require the Commissioner of Food and Drugs to develop a list of pathogens and microorganisms that infant formula manufacturers must test for in infant formula manufacturing facilities and finished infant formula products, which list shall include clostridium botulinum and such other pathogens and microorganisms as the Secretary designates; ``(ii) specify the recommended frequency of environmental testing, including requirements for testing in Zones 2 and 3 of an infant formula manufacturing facility; ``(iii) require the manufacturer of an infant formula to submit to the Secretary a written notification of any positive test result for a pathogen or microorganism referred to in clause (i) in infant formula, not later than one business day following the date of the result, even if the formula has not left the control of the manufacturer; ``(iv) for the purposes of inspections conducted under this Act, require the manufacturer of an infant formula to retain records of any positive test result for a pathogen or microorganism referred to in clause (i)-- ``(I) in infant formula; or ``(II) in the infant formula manufacturing facility of the manufacturer; and ``(v) require Commissioner of Food and Drugs to establish and enforce clear, consistent inspection and compliance standards for all infant formula products, regardless of their country of origin. ``(C) In this paragraph: ``(i) The term `Zone 2', with respect to an infant formula manufacturing facility, means areas directly adjacent to locations where infant formula could be exposed during manufacturing, but that are not food-contact surfaces. ``(ii) The term `Zone 3', with respect to an infant formula manufacturing facility, means areas further away from direct infant formula exposure than Zone 2, yet still within the processing environment; contamination in Zone 3 could reach Zone 2 (and thus the infant formula) through movement of people, equipment, or airflow.''. (2) Deadline.--Not later than 90 days after the date of enactment of this Act, the Secretary shall issue final regulations under section 412(b)(5)(A) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1) of this subsection). (b) Congressional Notification Requirements.--Section 412 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a) is amended by adding at the end the following: ``(n) Congressional Notification Requirements.--(1) If the Secretary receives from a manufacturer a written notification of any test result that is a positive analytical result for a pathogen or microorganism in finished infant formula pursuant to subsection (b)(5)(B)(iii), the Secretary shall, not later than one business day following the date of such receipt, provide a written notice of such receipt to the appropriate committees of Congress. ``(2) If the Food and Drug Administration issues an `official action indicated' classification (or an equivalent classification) following an inspection of an infant formula manufacturing facility, the Secretary shall, not later than one business day following the date of such issuance, provide a written notice of such issuance to the appropriate committees of Congress. ``(3) In this subsection, the term `appropriate committees of Congress' means-- ``(A) the Committee on Appropriations and the Committee on Energy and Commerce of the House of Representatives; and ``(B) the Committee on Appropriations and the Committee on Health, Education, Labor, and Pensions of the Senate.''. (c) Conforming Amendment.--Section 412(b)(4)(A)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b)(4)(A)(i)) is amended by striking ``paragraph (2)(B)'' and inserting ``paragraphs (2)(B) and (5)(A)''. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Infant Formula Safety Modernization Act of 2026\nSummary: This act introduces stricter controls and mandatory bacterial testing for infant formula products. It aims to ensure that formula sold in stores is safe for babies by requiring faster reporting of contamination.\nKey Points: Mandatory testing of finished formula and production facilities for dangerous pathogens., Manufacturers must report any positive test results for bacteria within one business day., Consistent safety and inspection standards for both domestic and imported infant formula., Fast-tracked notification to Congress regarding safety issues or failed facility inspections.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": true,\n  \"issue\": \"none\"\n}"
    },
    {
      "timestamp": "2026-03-27T12:15:53.872Z",
      "source_url": "https://www.congress.gov/119/bills/hr7867/BILLS-119hr7867ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7867 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7867 To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 9, 2026 Ms. DeLauro (for herself, Mrs. Grijalva, Mr. Panetta, Ms. Jacobs, Ms. Norton, Ms. Wilson of Florida, Mr. Bishop, Ms. Williams of Georgia, Mr. Pappas, Mr. Quigley, Mr. Krishnamoorthi, Ms. Schakowsky, Ms. Tlaib, Mr. Thanedar, Ms. Ross, Mr. Van Drew, Ms. Dean of Pennsylvania, and Mr. Cohen) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Infant Formula Safety Modernization Act of 2026''. SEC. 2. MEASURES TO ENHANCE THE SAFETY OF INFANT FORMULA. (a) Good Manufacturing Practices.-- (1) In general.--Section 412(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b)) is amended by adding at the end the following: ``(5)(A) The Secretary shall by regulation update the good manufacturing practices for infant formulas established under this subsection to require the manufacturer of an infant formula to conduct pathogen and microorganism testing of-- ``(i) the infant formula manufacturing facilities of the manufacturer; and ``(ii) in addition to other applicable testing requirements under this Act, the finished infant formula product of the manufacturer. ``(B) The regulations issued under subparagraph (A) shall-- ``(i) require the Commissioner of Food and Drugs to develop a list of pathogens and microorganisms that infant formula manufacturers must test for in infant formula manufacturing facilities and finished infant formula products, which list shall include clostridium botulinum and such other pathogens and microorganisms as the Secretary designates; ``(ii) specify the recommended frequency of environmental testing, including requirements for testing in Zones 2 and 3 of an infant formula manufacturing facility; ``(iii) require the manufacturer of an infant formula to submit to the Secretary a written notification of any positive test result for a pathogen or microorganism referred to in clause (i) in infant formula, not later than one business day following the date of the result, even if the formula has not left the control of the manufacturer; ``(iv) for the purposes of inspections conducted under this Act, require the manufacturer of an infant formula to retain records of any positive test result for a pathogen or microorganism referred to in clause (i)-- ``(I) in infant formula; or ``(II) in the infant formula manufacturing facility of the manufacturer; and ``(v) require Commissioner of Food and Drugs to establish and enforce clear, consistent inspection and compliance standards for all infant formula products, regardless of their country of origin. ``(C) In this paragraph: ``(i) The term `Zone 2', with respect to an infant formula manufacturing facility, means areas directly adjacent to locations where infant formula could be exposed during manufacturing, but that are not food-contact surfaces. ``(ii) The term `Zone 3', with respect to an infant formula manufacturing facility, means areas further away from direct infant formula exposure than Zone 2, yet still within the processing environment; contamination in Zone 3 could reach Zone 2 (and thus the infant formula) through movement of people, equipment, or airflow.''. (2) Deadline.--Not later than 90 days after the date of enactment of this Act, the Secretary shall issue final regulations under section 412(b)(5)(A) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1) of this subsection). (b) Congressional Notification Requirements.--Section 412 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a) is amended by adding at the end the following: ``(n) Congressional Notification Requirements.--(1) If the Secretary receives from a manufacturer a written notification of any test result that is a positive analytical result for a pathogen or microorganism in finished infant formula pursuant to subsection (b)(5)(B)(iii), the Secretary shall, not later than one business day following the date of such receipt, provide a written notice of such receipt to the appropriate committees of Congress. ``(2) If the Food and Drug Administration issues an `official action indicated' classification (or an equivalent classification) following an inspection of an infant formula manufacturing facility, the Secretary shall, not later than one business day following the date of such issuance, provide a written notice of such issuance to the appropriate committees of Congress. ``(3) In this subsection, the term `appropriate committees of Congress' means-- ``(A) the Committee on Appropriations and the Committee on Energy and Commerce of the House of Representatives; and ``(B) the Committee on Appropriations and the Committee on Health, Education, Labor, and Pensions of the Senate.''. (c) Conforming Amendment.--Section 412(b)(4)(A)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b)(4)(A)(i)) is amended by striking ``paragraph (2)(B)'' and inserting ``paragraphs (2)(B) and (5)(A)''. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o modernizacji bezpieczeństwa mleka modyfikowanego dla niemowląt z 2026 roku\",\n  \"pl_summary\": \"Ustawa wprowadza surowsze kontrole i obowiązkowe testy na obecność bakterii w mleku modyfikowanym dla niemowląt. Dzięki temu rodzice mogą mieć większą pewność, że produkty dostępne w sklepach są bezpieczne i wolne od groźnych drobnoustrojów.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie obowiązkowych testów gotowych produktów oraz fabryk na obecność groźnych bakterii.\",\n    \"Producenci muszą zgłaszać każdy wykryty przypadek zanieczyszczenia w ciągu jednego dnia roboczego.\",\n    \"Ujednolicenie standardów kontroli dla mleka modyfikowanego produkowanego w USA oraz importowanego z zagranicy.\",\n    \"Obowiązek natychmiastowego informowania Kongresu o wykrytych zagrożeniach lub negatywnych wynikach inspekcji w zakładach.\"\n  ],\n  \"eng_ai_title\": \"Infant Formula Safety Modernization Act of 2026\",\n  \"eng_summary\": \"This act introduces stricter controls and mandatory bacterial testing for infant formula products. It aims to ensure that formula sold in stores is safe for babies by requiring faster reporting of contamination.\",\n  \"eng_key_points\": [\n    \"Mandatory testing of finished formula and production facilities for dangerous pathogens.\",\n    \"Manufacturers must report any positive test results for bacteria within one business day.\",\n    \"Consistent safety and inspection standards for both domestic and imported infant formula.\",\n    \"Fast-tracked notification to Congress regarding safety issues or failed facility inspections.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Modernisierung der Sicherheit von Säuglingsnahrung 2026\",\n  \"de_summary\": \"Dieses Gesetz führt strengere Kontrollen und obligatorische Bakterientests für Säuglingsnahrung ein. Es soll sicherstellen, dass im Handel erhältliche Produkte sicher sind, indem Verunreinigungen schneller gemeldet werden müssen.\",\n  \"de_key_points\": [\n    \"Verpflichtende Tests von Endprodukten und Produktionsstätten auf gefährliche Krankheitserreger.\",\n    \"Hersteller müssen positive Testergebnisse innerhalb eines Werktages an die Behörden melden.\",\n    \"Einheitliche Inspektionsstandards für inländische und importierte Säuglingsnahrungsprodukte.\",\n    \"Schnelle Benachrichtigung des Kongresses bei Sicherheitsmängeln oder beanstandeten Fabrikinspektionen.\"\n  ],\n  \"fr_ai_title\": \"Loi de 2026 sur la modernisation de la sécurité des préparations pour nourrissons\",\n  \"fr_summary\": \"Cette loi impose des contrôles plus stricts et des tests bactériens obligatoires pour le lait maternisé. Elle vise à garantir la sécurité des produits en magasin en exigeant un signalement rapide de toute contamination.\",\n  \"fr_key_points\": [\n    \"Tests obligatoires des produits finis et des usines pour détecter les agents pathogènes dangereux.\",\n    \"Les fabricants doivent signaler tout résultat de test positif dans un délai d'un jour ouvrable.\",\n    \"Normes d'inspection uniformes pour les préparations pour nourrissons nationales et importées.\",\n    \"Information rapide du Congrès en cas de problèmes de sécurité ou d'inspections d'usine défavorables.\"\n  ],\n  \"es_ai_title\": \"Ley de Modernización de la Seguridad de las Fórmulas Infantiles de 2026\",\n  \"es_summary\": \"Esta ley introduce controles más estrictos y pruebas bacterianas obligatorias para las fórmulas infantiles. Busca garantizar que los productos en las tiendas sean seguros mediante el reporte rápido de contaminaciones.\",\n  \"es_key_points\": [\n    \"Pruebas obligatorias de patógenos peligrosos en productos terminados y plantas de producción.\",\n    \"Los fabricantes deben informar sobre cualquier resultado positivo de bacterias en un plazo de un día hábil.\",\n    \"Estándares de inspección uniformes para fórmulas infantiles tanto nacionales como importadas.\",\n    \"Notificación rápida al Congreso sobre problemas de seguridad o resultados negativos en las inspecciones de fábricas.\"\n  ],\n  \"it_ai_title\": \"Legge del 2026 sulla modernizzazione della sicurezza del latte artificiale per neonati\",\n  \"it_summary\": \"Questa legge introduce controlli più severi e test batterici obbligatori per il latte artificiale. L'obiettivo è garantire la sicurezza dei prodotti in commercio richiedendo la segnalazione rapida di eventuali contaminazioni.\",\n  \"it_key_points\": [\n    \"Test obbligatori su prodotti finiti e impianti di produzione per la ricerca di agenti patogeni pericolosi.\",\n    \"Obbligo per i produttori di segnalare i risultati positivi ai test entro un solo giorno lavorativo.\",\n    \"Standard di ispezione uniformi per il latte artificiale prodotto internamente e quello importato.\",\n    \"Notifica rapida al Congresso in caso di rischi per la sicurezza o esiti negativi delle ispezioni negli stabilimenti.\"\n  ],\n  \"nl_ai_title\": \"Wet Modernisering Veiligheid Babyvoeding 2026\",\n  \"nl_summary\": \"Deze wet voert strengere controles en verplichte bacterietesten in voor babyvoeding. Het doel is om de veiligheid van producten in de winkel te waarborgen door snellere melding van besmettingen te eisen.\",\n  \"nl_key_points\": [\n    \"Verplichte testen van eindproducten en productiefaciliteiten op gevaarlijke ziekteverwekkers.\",\n    \"Fabrikanten moeten positieve testresultaten voor bacteriën binnen één werkdag melden.\",\n    \"Uniforme inspectienormen voor zowel binnenlandse als geïmporteerde babyvoeding.\",\n    \"Snelle melding aan het Congres bij veiligheidsproblemen of onvoldoende resultaten bij fabrieksinspecties.\"\n  ],\n  \"pt_ai_title\": \"Lei de Modernização da Segurança das Fórmulas Infantis de 2026\",\n  \"pt_summary\": \"Esta lei introduz controlos mais rigorosos e testes bacterianos obrigatórios para fórmulas infantis. Visa garantir que os produtos à venda sejam seguros através do reporte rápido de qualquer contaminação.\",\n  \"pt_key_points\": [\n    \"Testes obrigatórios de agentes patogénicos perigosos em produtos acabados e unidades de produção.\",\n    \"Os fabricantes devem comunicar quaisquer resultados positivos de testes no prazo de um dia útil.\",\n    \"Padrões de inspeção uniformes para fórmulas infantis nacionais e importadas.\",\n    \"Notificação rápida ao Congresso sobre problemas de segurança ou falhas em inspeções de fábricas.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Family\"\n  ]\n}"
    }
  ]
}